Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum injection for symptom reduction in temporomandibular disorders
IRCT20130710013938N4Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of neuronox in temporomandibular disorder (TMD), sponsored by Tabriz University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
neuronox
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on IRCT20130710013938N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130710013938N4.